AIRSCULPT TECHNOLOGIES INC (AIRS) Stock Fundamental Analysis
NASDAQ:AIRS - Nasdaq - US0094961002 - Common Stock
We assign a fundamental rating of 3 out of 10 to AIRS. AIRS was compared to 108 industry peers in the Health Care Providers & Services industry. AIRS has a bad profitability rating. Also its financial health evaluation is rather negative. AIRS is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year AIRS has reported negative net income.
AIRS had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: AIRS reported negative net income in multiple years.
Each year in the past 5 years AIRS had a positive operating cash flow.
1.2 Ratios
The Return On Assets of AIRS (-3.74%) is comparable to the rest of the industry.
AIRS's Return On Equity of -9.44% is in line compared to the rest of the industry. AIRS outperforms 43.93% of its industry peers.
AIRS has a Return On Invested Capital (1.60%) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.74% | ||
| ROE | -9.44% | ||
| ROIC | 1.6% |
ROA(3y)-1.41%
ROA(5y)-0.26%
ROE(3y)-4.47%
ROE(5y)-1.82%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Operating Margin, with a value of 1.96%, AIRS is in line with its industry, outperforming 51.40% of the companies in the same industry.
AIRS's Operating Margin has declined in the last couple of years.
AIRS's Gross Margin of 64.98% is amongst the best of the industry. AIRS outperforms 86.92% of its industry peers.
In the last couple of years the Gross Margin of AIRS has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.96% | ||
| PM (TTM) | N/A | ||
| GM | 64.98% |
OM growth 3Y-33.27%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.91%
GM growth 5YN/A
2. Health
2.1 Basic Checks
AIRS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for AIRS has been increased compared to 1 year ago.
AIRS has a better debt/assets ratio than last year.
2.2 Solvency
AIRS has an Altman-Z score of 2.20. This is not the best score and indicates that AIRS is in the grey zone with still only limited risk for bankruptcy at the moment.
AIRS has a Altman-Z score of 2.20. This is comparable to the rest of the industry: AIRS outperforms 52.34% of its industry peers.
The Debt to FCF ratio of AIRS is 58.70, which is on the high side as it means it would take AIRS, 58.70 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of AIRS (58.70) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.80 indicates that AIRS is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.80, AIRS perfoms like the industry average, outperforming 40.19% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.8 | ||
| Debt/FCF | 58.7 | ||
| Altman-Z | 2.2 |
ROIC/WACC0.19
WACC8.62%
2.3 Liquidity
AIRS has a Current Ratio of 0.51. This is a bad value and indicates that AIRS is not financially healthy enough and could expect problems in meeting its short term obligations.
AIRS has a worse Current ratio (0.51) than 90.65% of its industry peers.
A Quick Ratio of 0.51 indicates that AIRS may have some problems paying its short term obligations.
AIRS has a worse Quick ratio (0.51) than 87.85% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.51 | ||
| Quick Ratio | 0.51 |
3. Growth
3.1 Past
AIRS shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -7.69%.
The Revenue has decreased by -0.12% in the past year.
Measured over the past years, AIRS shows a very strong growth in Revenue. The Revenue has been growing by 46.12% on average per year.
EPS 1Y (TTM)-7.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-233.33%
Revenue 1Y (TTM)-0.12%
Revenue growth 3Y46.12%
Revenue growth 5YN/A
Sales Q2Q%-9.07%
3.2 Future
The Earnings Per Share is expected to grow by 75.67% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 6.69% on average over the next years.
EPS Next Y7.56%
EPS Next 2Y55.72%
EPS Next 3Y59.18%
EPS Next 5Y75.67%
Revenue Next Year-5.5%
Revenue Next 2Y1.93%
Revenue Next 3Y4.84%
Revenue Next 5Y6.69%
3.3 Evolution
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for AIRS. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 149.13, AIRS can be considered very expensive at the moment.
AIRS's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. AIRS is more expensive than 62.62% of the companies in the same industry.
AIRS's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 24.37.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 149.13 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as AIRS.
AIRS's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 245.57 | ||
| EV/EBITDA | 24.41 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
AIRS's earnings are expected to grow with 59.18% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y55.72%
EPS Next 3Y59.18%
5. Dividend
5.1 Amount
No dividends for AIRS!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
AIRSCULPT TECHNOLOGIES INC
NASDAQ:AIRS (1/22/2025, 4:30:00 PM)
After market: 5.07 0 (0%)5.07
-0.22 (-4.16%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners23.03%
Inst Owner Change-0.04%
Ins Owners26.39%
Ins Owner Change0.08%
Market Cap293.45M
Analysts74.55
Price Target7.65 (50.89%)
Short Float %20.49%
Short Ratio10.35
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0.01
Dividend Growth(5Y)N/A
DP-2.43%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-170.97%
Min EPS beat(2)-245.86%
Max EPS beat(2)-96.08%
EPS beat(4)1
Avg EPS beat(4)-60.97%
Min EPS beat(4)-492.16%
Max EPS beat(4)590.2%
EPS beat(8)2
Avg EPS beat(8)-69.21%
EPS beat(12)3
Avg EPS beat(12)-124.83%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-4.78%
Min Revenue beat(2)-9.52%
Max Revenue beat(2)-0.03%
Revenue beat(4)0
Avg Revenue beat(4)-4.68%
Min Revenue beat(4)-9.52%
Max Revenue beat(4)-0.03%
Revenue beat(8)2
Avg Revenue beat(8)-1.92%
Revenue beat(12)5
Avg Revenue beat(12)-0.74%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-4.25%
PT rev (3m)91.49%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-153.76%
EPS NY rev (1m)0%
EPS NY rev (3m)-81.25%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-21.98%
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)0.24%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 149.13 | ||
| P/S | 1.55 | ||
| P/FCF | 245.57 | ||
| P/OCF | 21.73 | ||
| P/B | 3.56 | ||
| P/tB | N/A | ||
| EV/EBITDA | 24.41 |
EPS(TTM)-0.14
EYN/A
EPS(NY)0.03
Fwd EY0.67%
FCF(TTM)0.02
FCFY0.41%
OCF(TTM)0.23
OCFY4.6%
SpS3.26
BVpS1.43
TBVpS-0.73
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.74% | ||
| ROE | -9.44% | ||
| ROCE | 2.03% | ||
| ROIC | 1.6% | ||
| ROICexc | 1.66% | ||
| ROICexgc | 5.59% | ||
| OM | 1.96% | ||
| PM (TTM) | N/A | ||
| GM | 64.98% | ||
| FCFM | 0.63% |
ROA(3y)-1.41%
ROA(5y)-0.26%
ROE(3y)-4.47%
ROE(5y)-1.82%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-29.15%
ROICexcg growth 5YN/A
ROICexc growth 3Y-5.14%
ROICexc growth 5YN/A
OM growth 3Y-33.27%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.91%
GM growth 5YN/A
F-Score4
Asset Turnover0.91
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.8 | ||
| Debt/FCF | 58.7 | ||
| Debt/EBITDA | 4.38 | ||
| Cap/Depr | 107.34% | ||
| Cap/Sales | 6.52% | ||
| Interest Coverage | 0.62 | ||
| Cash Conversion | 88.98% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.51 | ||
| Quick Ratio | 0.51 | ||
| Altman-Z | 2.2 |
F-Score4
WACC8.62%
ROIC/WACC0.19
Cap/Depr(3y)121.64%
Cap/Depr(5y)103.97%
Cap/Sales(3y)6.02%
Cap/Sales(5y)6.94%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-7.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-233.33%
EPS Next Y7.56%
EPS Next 2Y55.72%
EPS Next 3Y59.18%
EPS Next 5Y75.67%
Revenue 1Y (TTM)-0.12%
Revenue growth 3Y46.12%
Revenue growth 5YN/A
Sales Q2Q%-9.07%
Revenue Next Year-5.5%
Revenue Next 2Y1.93%
Revenue Next 3Y4.84%
Revenue Next 5Y6.69%
EBIT growth 1Y33.42%
EBIT growth 3Y-2.49%
EBIT growth 5YN/A
EBIT Next Year111.75%
EBIT Next 3Y51.67%
EBIT Next 5Y52.22%
FCF growth 1Y217.16%
FCF growth 3Y10.98%
FCF growth 5YN/A
OCF growth 1Y11.6%
OCF growth 3Y19.72%
OCF growth 5YN/A